RxDoctor Payments Data

Robert Solarczyk, PA

Physician Assistant · Cumberland, MDNPI 1982691192

Payments from drug & device makers

$3,601in general payments, 2019–2025

Across 219 payments — averaging $16.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
  • Collegium Pharmaceutical, Inc.$908
  • Medtronic$242
  • Redhill Biopharma Inc.$142
  • Mallinckrodt Hospital Products Inc.$125
  • Biodelivery Sciences International, Inc.$113
  • plus $734 from 17 others

What the payments were for

  • Food & beverage$3,601100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,601 in reported general payments places this provider in the 90th percentile of 2,567 physician assistant providers in Maryland.

See all physician assistant providers in Maryland

Medicare billing

Part B allowed, 2024
$338,814
Medicare patients
395
Services billed
3,053

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate223$119,241
RelistorMethylnaltrexone Bromide26$60,381
BelbucaBuprenorphine Hcl51$46,888
NucyntaTapentadol Hcl26$43,428
OxycontinOxycodone Hcl98$41,902
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen1,064$33,403
Buprenorphine88$21,705
Oxycodone Hcl888$16,422
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen680$14,184
MovantikNaloxegol Oxalate17$10,165
Nucynta ErTapentadol Hcl13$8,499
Morphine Sulfate ErMorphine Sulfate402$8,317
Fentanyl91$6,752
Gabapentin448$6,616
SymproicNaldemedine Tosylate12$6,239

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca, Nucynta, Nucynta Er$908$218,056313 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$1,337$60,38126 claims
Redhill Biopharma Inc.Movantik$142$10,16517 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,567 physician assistant providers in Maryland.

Other physician assistant in Cumberland

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →